A formulation includes one ormore active ingredients of poor water solubility for medical or non-medical use in the rearing of animals. The formulation is suitable for administration to the animals via their drinking water. It exhibits superior stability. The formulation comprises an active ingredient,a thickener combination and water, wherein the thickener combination comprises at least one thickener selected from the following groups A, B, C and D: (A)cellulose derivatives, such as methyl cellulose, sodium carboxy methyl cellulose, (B) non-cellulosic polysaccharide thickeners such as xanthan gums, Arabic gum, (C)oss-linked polyacrylic acid polymers, (D)ydrocolloidal hydrated silicates.

The present invention relates to a stable pharmaceutical composition comprising tamsulosin or a pharmaceutically acceptable salt or solvate thereof in a solid dosage form and to a process for preparing such a composition.

A controlled release pharmaceutical composition having a specific ratio of sodium alginate and sodium-calcium alginate is given, which is suitable for once-daily administration of poorly soluble drugs.

The present invention relates to a stable pharmaceutical composition comprising tamsulosin or a pharmaceutically acceptable salt or solvate thereofin a solid dosage form and to a process for preparing such a composition.